Skip to main content

BC Cancer Agency Joins Illumina Network; Ambry Offering MiSeq Services

NEW YORK (GenomeWeb News) – The British Columbia Cancer Agency Genome Science Center has joined the Illumina Genome Network, the San Diego-based firm said this week.

Research institutes that join the IGN have completed the firm's Certified Service Provider certification. Each of the partners in the network also have at least 10 Illumina sequencing systems.

The BC Cancer Agency is part of the Canadian Provincial Health Services Authority and provides a range of oncology services to patients in the province. Its Genome Science Center provides genomic services to researchers around the world.

In a separate announcement, Ambry Genetics said that it has begun offering services on Illumina's MiSeq next-generation sequencing platform. The Aliso, Viejo, Calif.-based CLIA-certified lab and analytical services provider, has offered services on Illumina's other sequencing platforms since 2007 and is a Certified Service Provider for the firm.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.